BreatheIN: Realising the Clinical Potential of Oligonucleotide Rx for Respiratory Disease

Research output: Contribution to conferenceOtherpeer-review

Original languageEnglish
Publication statusPublished - 1 Feb 2017
EventMedImmune & AstraZeneca joint presentation - Cambridge, United Kingdom
Duration: 1 Feb 20171 Feb 2017

Seminar

SeminarMedImmune & AstraZeneca joint presentation
CountryUnited Kingdom
CityCambridge
Period1/02/171/02/17

Cite this